产品名称：LDE-225 （SMO antagonist）
产品编号：SANT-02/10/50
品牌；StemRD
厂家：StemRD
产品规格：5/25/100ug
储存条件：-80℃
到货时间：2-5天

产品信息

Hedgehog（Hh） 信号通路调节胚胎发育和成体许多组织器官干细胞的自我更新与增殖。然而，那些在正常发育过程中受到Hh信号通路调节的组织器官，在该信号通路异常时常常发 生肿瘤。这些肿瘤包括肝癌、神经胶质瘤、基底细胞癌、横纹肌肉瘤、胰腺癌、小细胞肺癌、胃癌、结肠癌、前列腺癌、黑色素瘤和多发性骨髓瘤等。

LDE225 (NVP-LDE225):
A potent antagonist of SMO (smoothened). This small molecule compound is a hedgehog pathway inhibitor by directly binding to SMO. This molecule has been developed by the Novartis Pharma for clinical application against hedgehog-dependent cancers.

Purity:
Greater than 99% as determined by LC/MS analysis. LC/MS and/or NMR data available upon request.

Biological Activity:
In a cell-based assay measuring the activation of the Gli-1 reporter gene, this compound gives IC50 of 15-40 nM.